 Jeffrey Kavanaugh
Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Staphylococcus aureus | 12 | 2022 | 386 | 2.400 |
Why?
| | Quorum Sensing | 12 | 2019 | 72 | 1.980 |
Why?
| | Staphylococcal Infections | 11 | 2022 | 338 | 1.780 |
Why?
| | Biofilms | 9 | 2022 | 222 | 1.640 |
Why?
| | Bacterial Proteins | 14 | 2020 | 740 | 1.520 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 10 | 2022 | 193 | 1.060 |
Why?
| | Hemoglobins | 7 | 2005 | 313 | 0.860 |
Why?
| | Lipoproteins | 2 | 2021 | 162 | 0.810 |
Why?
| | Cathepsin G | 1 | 2021 | 6 | 0.780 |
Why?
| | Phagocytosis | 1 | 2021 | 355 | 0.670 |
Why?
| | Neutrophils | 2 | 2021 | 1171 | 0.650 |
Why?
| | Peptides, Cyclic | 6 | 2019 | 262 | 0.560 |
Why?
| | Hemoglobin A | 6 | 1999 | 21 | 0.550 |
Why?
| | Homoserine | 2 | 2013 | 6 | 0.520 |
Why?
| | Yersinia pestis | 2 | 2013 | 34 | 0.510 |
Why?
| | Hemoglobins, Abnormal | 4 | 2005 | 10 | 0.500 |
Why?
| | Lactones | 2 | 2013 | 56 | 0.490 |
Why?
| | Environment | 1 | 2016 | 340 | 0.470 |
Why?
| | Staphylococcal Skin Infections | 3 | 2020 | 30 | 0.430 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1318 | 0.410 |
Why?
| | Gene Expression Regulation, Bacterial | 5 | 2016 | 284 | 0.360 |
Why?
| | Protein Subunits | 4 | 2005 | 205 | 0.350 |
Why?
| | Virulence | 6 | 2022 | 231 | 0.330 |
Why?
| | Mass Spectrometry | 4 | 2019 | 643 | 0.330 |
Why?
| | Anti-Bacterial Agents | 7 | 2022 | 1486 | 0.320 |
Why?
| | Carrier Proteins | 1 | 2011 | 703 | 0.300 |
Why?
| | Protein Conformation | 6 | 2004 | 822 | 0.290 |
Why?
| | Serine Endopeptidases | 1 | 2007 | 102 | 0.280 |
Why?
| | Tyrosine | 2 | 2005 | 218 | 0.280 |
Why?
| | Globins | 2 | 2005 | 22 | 0.280 |
Why?
| | Models, Molecular | 11 | 2016 | 1391 | 0.280 |
Why?
| | Protein Structure, Tertiary | 4 | 2011 | 804 | 0.280 |
Why?
| | Crystallography, X-Ray | 8 | 2005 | 409 | 0.250 |
Why?
| | Mutation | 8 | 2021 | 3371 | 0.240 |
Why?
| | Cell Membrane | 3 | 2021 | 683 | 0.230 |
Why?
| | Amino Acid Substitution | 2 | 2001 | 267 | 0.220 |
Why?
| | Micrococcal Nuclease | 2 | 2013 | 19 | 0.210 |
Why?
| | Membrane Proteins | 2 | 2013 | 1033 | 0.210 |
Why?
| | Cephalexin | 1 | 2022 | 8 | 0.210 |
Why?
| | Staphylococcus epidermidis | 2 | 2020 | 71 | 0.210 |
Why?
| | Tryptophan | 2 | 2005 | 136 | 0.200 |
Why?
| | Pneumonia, Bacterial | 1 | 2022 | 108 | 0.200 |
Why?
| | Coinfection | 1 | 2022 | 120 | 0.200 |
Why?
| | Virulence Factors | 4 | 2019 | 139 | 0.190 |
Why?
| | DNA, Bacterial | 2 | 2020 | 309 | 0.190 |
Why?
| | Extracellular Traps | 1 | 2021 | 40 | 0.190 |
Why?
| | Binding Sites | 4 | 2011 | 1182 | 0.190 |
Why?
| | Trans-Activators | 4 | 2019 | 369 | 0.190 |
Why?
| | Protein Structure, Quaternary | 4 | 2005 | 115 | 0.190 |
Why?
| | Cysteine Proteases | 1 | 2020 | 3 | 0.180 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2001 | 346 | 0.180 |
Why?
| | Skin | 3 | 2020 | 668 | 0.180 |
Why?
| | Microbial Sensitivity Tests | 5 | 2022 | 299 | 0.170 |
Why?
| | Blotting, Southwestern | 1 | 2019 | 2 | 0.170 |
Why?
| | Molecular Sequence Data | 5 | 2011 | 2796 | 0.170 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2019 | 62 | 0.170 |
Why?
| | Static Electricity | 1 | 2019 | 117 | 0.160 |
Why?
| | Plant Extracts | 3 | 2017 | 153 | 0.150 |
Why?
| | Amino Acid Sequence | 3 | 2011 | 2003 | 0.150 |
Why?
| | Anacardiaceae | 1 | 2017 | 4 | 0.150 |
Why?
| | Host-Pathogen Interactions | 2 | 2019 | 296 | 0.140 |
Why?
| | Influenza, Human | 1 | 2022 | 549 | 0.140 |
Why?
| | Staphylococcus lugdunensis | 1 | 2016 | 2 | 0.140 |
Why?
| | Cyclohexanones | 1 | 2016 | 8 | 0.140 |
Why?
| | Dermatitis, Atopic | 1 | 2020 | 337 | 0.140 |
Why?
| | Mice | 11 | 2022 | 15085 | 0.140 |
Why?
| | Mice, Inbred BALB C | 4 | 2022 | 1169 | 0.130 |
Why?
| | Fagaceae | 1 | 2015 | 2 | 0.130 |
Why?
| | Oleanolic Acid | 1 | 2015 | 9 | 0.130 |
Why?
| | Humans | 26 | 2022 | 115859 | 0.130 |
Why?
| | Microbiota | 2 | 2020 | 652 | 0.130 |
Why?
| | Antibodies, Monoclonal | 1 | 2022 | 1264 | 0.130 |
Why?
| | Skin Diseases | 1 | 2017 | 124 | 0.130 |
Why?
| | Oxyhemoglobins | 1 | 1995 | 19 | 0.130 |
Why?
| | Emodin | 1 | 2015 | 3 | 0.130 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2016 | 515 | 0.120 |
Why?
| | Penicillium | 1 | 2014 | 6 | 0.120 |
Why?
| | Anthraquinones | 1 | 2014 | 9 | 0.120 |
Why?
| | Rabbits | 4 | 2019 | 754 | 0.120 |
Why?
| | Arginine | 1 | 1995 | 242 | 0.110 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2014 | 165 | 0.110 |
Why?
| | Oxygen | 4 | 2005 | 837 | 0.110 |
Why?
| | Hydrogen Bonding | 3 | 2005 | 145 | 0.110 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 2013 | 477 | 0.110 |
Why?
| | Immunity, Innate | 1 | 2019 | 735 | 0.110 |
Why?
| | Carbon Monoxide | 2 | 2005 | 67 | 0.110 |
Why?
| | Models, Genetic | 1 | 2016 | 579 | 0.110 |
Why?
| | Protein Binding | 2 | 2011 | 1918 | 0.110 |
Why?
| | Hydrastis | 1 | 2012 | 3 | 0.110 |
Why?
| | Berberine | 1 | 2012 | 6 | 0.110 |
Why?
| | Protein Structure, Secondary | 1 | 1993 | 327 | 0.100 |
Why?
| | Animals | 12 | 2022 | 32158 | 0.100 |
Why?
| | Repressor Proteins | 1 | 2015 | 369 | 0.100 |
Why?
| | Cells, Cultured | 4 | 2021 | 3914 | 0.100 |
Why?
| | Chlorides | 1 | 1992 | 130 | 0.100 |
Why?
| | Conserved Sequence | 1 | 2011 | 220 | 0.090 |
Why?
| | Sequence Alignment | 1 | 2011 | 328 | 0.090 |
Why?
| | Kinetics | 3 | 2005 | 1568 | 0.090 |
Why?
| | Protein Kinases | 1 | 2013 | 306 | 0.090 |
Why?
| | Staphylococcus | 1 | 2010 | 69 | 0.090 |
Why?
| | Ethanol | 1 | 2015 | 549 | 0.090 |
Why?
| | Crystallization | 4 | 2004 | 138 | 0.090 |
Why?
| | X-Ray Diffraction | 4 | 1993 | 84 | 0.080 |
Why?
| | In Vitro Techniques | 2 | 2015 | 1044 | 0.080 |
Why?
| | Alcoholism | 1 | 2015 | 715 | 0.080 |
Why?
| | Genes, Reporter | 1 | 2009 | 260 | 0.080 |
Why?
| | Recombinant Proteins | 3 | 2015 | 1244 | 0.080 |
Why?
| | Cathelicidins | 2 | 2020 | 39 | 0.080 |
Why?
| | Mice, Inbred C57BL | 4 | 2020 | 4779 | 0.080 |
Why?
| | Luminescent Proteins | 1 | 2009 | 169 | 0.080 |
Why?
| | Toll-Like Receptor 2 | 2 | 2021 | 114 | 0.080 |
Why?
| | Molecular Structure | 3 | 2014 | 447 | 0.070 |
Why?
| | Antimicrobial Cationic Peptides | 2 | 2020 | 76 | 0.070 |
Why?
| | beta-Lactamases | 1 | 2007 | 26 | 0.070 |
Why?
| | Metalloproteases | 1 | 2007 | 37 | 0.070 |
Why?
| | Biological Assay | 1 | 2007 | 114 | 0.070 |
Why?
| | Keratinocytes | 2 | 2020 | 218 | 0.070 |
Why?
| | Substrate Specificity | 1 | 2007 | 357 | 0.070 |
Why?
| | Thermodynamics | 2 | 2001 | 388 | 0.070 |
Why?
| | Hemolysin Proteins | 2 | 2017 | 31 | 0.070 |
Why?
| | Ligands | 2 | 2005 | 570 | 0.070 |
Why?
| | Peptides | 1 | 2010 | 864 | 0.060 |
Why?
| | Inhibitory Concentration 50 | 2 | 2016 | 78 | 0.060 |
Why?
| | Mutagenesis, Insertional | 1 | 2005 | 60 | 0.060 |
Why?
| | Allosteric Regulation | 1 | 2005 | 84 | 0.060 |
Why?
| | Spectrum Analysis, Raman | 1 | 2005 | 41 | 0.060 |
Why?
| | Solutions | 1 | 2005 | 150 | 0.060 |
Why?
| | Dimerization | 1 | 2005 | 177 | 0.060 |
Why?
| | Inflammation | 1 | 2015 | 2502 | 0.060 |
Why?
| | Cross-Linking Reagents | 1 | 2005 | 182 | 0.060 |
Why?
| | Enzyme Inhibitors | 1 | 2007 | 758 | 0.060 |
Why?
| | Cytotoxins | 1 | 2022 | 17 | 0.050 |
Why?
| | Heparitin Sulfate | 1 | 2022 | 42 | 0.050 |
Why?
| | Cefadroxil | 1 | 2022 | 6 | 0.050 |
Why?
| | Cephalothin | 1 | 2022 | 6 | 0.050 |
Why?
| | Oxacillin | 1 | 2022 | 6 | 0.050 |
Why?
| | Methicillin | 1 | 2022 | 11 | 0.050 |
Why?
| | Cefazolin | 1 | 2022 | 18 | 0.050 |
Why?
| | Teichoic Acids | 1 | 2022 | 12 | 0.050 |
Why?
| | Macromolecular Substances | 2 | 1992 | 200 | 0.050 |
Why?
| | Toll-Like Receptor 1 | 1 | 2021 | 12 | 0.050 |
Why?
| | Lipoylation | 1 | 2021 | 16 | 0.050 |
Why?
| | Pancreatic Elastase | 1 | 2021 | 67 | 0.050 |
Why?
| | Catheter-Related Infections | 1 | 2022 | 61 | 0.050 |
Why?
| | Photolysis | 1 | 2001 | 79 | 0.050 |
Why?
| | Desmoglein 1 | 1 | 2020 | 3 | 0.050 |
Why?
| | Interleukin-8 | 1 | 2021 | 241 | 0.040 |
Why?
| | Valine | 3 | 1999 | 74 | 0.040 |
Why?
| | Methionine | 3 | 1999 | 145 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2004 | 833 | 0.040 |
Why?
| | Signal Transduction | 3 | 2021 | 4527 | 0.040 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2019 | 165 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2013 | 2807 | 0.040 |
Why?
| | Toxins, Biological | 1 | 2017 | 11 | 0.040 |
Why?
| | Soft Tissue Infections | 1 | 2017 | 30 | 0.030 |
Why?
| | Necrosis | 1 | 2017 | 211 | 0.030 |
Why?
| | Bacteria | 1 | 2022 | 730 | 0.030 |
Why?
| | Drug Discovery | 1 | 2016 | 124 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2017 | 3587 | 0.030 |
Why?
| | Hypersensitivity, Delayed | 1 | 2015 | 52 | 0.030 |
Why?
| | Interleukin-23 | 1 | 2015 | 15 | 0.030 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2015 | 60 | 0.030 |
Why?
| | Escherichia coli | 1 | 1999 | 730 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 1995 | 178 | 0.030 |
Why?
| | Bacterial Toxins | 1 | 2015 | 103 | 0.030 |
Why?
| | Bacterial Load | 1 | 2015 | 60 | 0.030 |
Why?
| | Neutrophil Infiltration | 1 | 2015 | 95 | 0.030 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 97 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2016 | 377 | 0.030 |
Why?
| | Drug Resistance, Bacterial | 1 | 2015 | 156 | 0.030 |
Why?
| | Plant Leaves | 1 | 2015 | 112 | 0.030 |
Why?
| | Sodium Chloride | 1 | 1995 | 136 | 0.030 |
Why?
| | Interleukin-17 | 1 | 2015 | 106 | 0.030 |
Why?
| | Peptide Hydrolases | 1 | 2015 | 109 | 0.030 |
Why?
| | Alleles | 1 | 2017 | 817 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 1995 | 511 | 0.030 |
Why?
| | Myeloid Cells | 1 | 2015 | 127 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 2004 | 0.030 |
Why?
| | Leukocytes | 1 | 2015 | 284 | 0.030 |
Why?
| | Microarray Analysis | 1 | 2013 | 120 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2015 | 197 | 0.030 |
Why?
| | Genes, Bacterial | 1 | 2013 | 156 | 0.030 |
Why?
| | Bacteremia | 1 | 2015 | 159 | 0.030 |
Why?
| | Regulon | 1 | 2013 | 33 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2015 | 321 | 0.030 |
Why?
| | Plants, Medicinal | 1 | 2012 | 19 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2590 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2015 | 370 | 0.030 |
Why?
| | T-Lymphocyte Subsets | 1 | 2015 | 383 | 0.030 |
Why?
| | Microbial Viability | 1 | 2013 | 79 | 0.030 |
Why?
| | Peritonitis | 1 | 2013 | 76 | 0.030 |
Why?
| | Chemistry, Physical | 1 | 1992 | 38 | 0.030 |
Why?
| | Anions | 1 | 1992 | 31 | 0.030 |
Why?
| | Alanine | 1 | 1992 | 103 | 0.030 |
Why?
| | Chemical Phenomena | 1 | 1992 | 81 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2015 | 423 | 0.030 |
Why?
| | Hemolysis | 1 | 2013 | 146 | 0.030 |
Why?
| | Male | 4 | 2022 | 56103 | 0.030 |
Why?
| | Gene Deletion | 1 | 2013 | 356 | 0.020 |
Why?
| | Sigma Factor | 1 | 2011 | 33 | 0.020 |
Why?
| | RNA Polymerase III | 1 | 2010 | 25 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 1130 | 0.020 |
Why?
| | Erythrocytes | 1 | 2015 | 590 | 0.020 |
Why?
| | Weight Loss | 1 | 2015 | 633 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2013 | 399 | 0.020 |
Why?
| | Lung | 1 | 2022 | 3683 | 0.020 |
Why?
| | Cell Line | 1 | 2015 | 2657 | 0.020 |
Why?
| | Plasmids | 1 | 2009 | 346 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2013 | 1095 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 402 | 0.020 |
Why?
| | Cytokines | 1 | 2015 | 1858 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2013 | 1550 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2009 | 1060 | 0.020 |
Why?
| | Female | 3 | 2019 | 60070 | 0.020 |
Why?
| | Transcription Factors | 1 | 2013 | 1535 | 0.020 |
Why?
| | Anaerobiosis | 1 | 2004 | 49 | 0.010 |
Why?
| | Histidine | 1 | 2004 | 57 | 0.010 |
Why?
| | Heme | 1 | 2004 | 56 | 0.010 |
Why?
| | Child | 1 | 2022 | 18537 | 0.010 |
Why?
| | Cysteine | 1 | 2004 | 173 | 0.010 |
Why?
| | Iron | 1 | 2004 | 235 | 0.010 |
Why?
| | Sulfhydryl Compounds | 1 | 2004 | 178 | 0.010 |
Why?
| | Hemoglobin M | 1 | 1999 | 2 | 0.010 |
Why?
| | Chemical Fractionation | 1 | 1999 | 28 | 0.010 |
Why?
| | Peptide Fragments | 1 | 1999 | 675 | 0.010 |
Why?
| | Computer Simulation | 1 | 1997 | 882 | 0.010 |
Why?
| | Glutamates | 1 | 1992 | 59 | 0.010 |
Why?
| | Acetylation | 1 | 1992 | 212 | 0.010 |
Why?
| | Aged | 1 | 1992 | 19292 | 0.000 |
Why?
|
|
Kavanaugh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|